Parathyroid hormone (1-84) - Kerun BiopharmaceuticalAlternative Names: Recombinant human parathyroid hormone (PTH) 1-84 - Kerun; rhPTH (1-84) - Kerun
Latest Information Update: 07 Mar 2016
At a glance
- Originator Kerun Biopharmaceutical
- Developer Heze Buchang Pharmaceutical; Kerun Biopharmaceutical
- Class Calcium regulators; Osteoporosis therapies; Peptide hormones
- Mechanism of Action Osteogenesis stimulants; Parathyroid hormone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Osteoporosis